Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
TolerRx, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapies to treat patients with immune-mediated diseases. TolerRxís therapies induce and maintain immunological tolerance, the process by which the immune system identifies and avoids attacking the bodyís own tissues and proteins. In addition to TRX4 in clinical development in type 1 diabetes and psoriasis, TolerRxís TRX1 monoclonal antibody is in Phase Ib clinical development in collaboration with Genentech, Inc. TolerRx also has research and discovery programs generating new products to induce immunological tolerance for the treatment of autoimmune diseases. ( www.tolerrx.com )
TolerRx , Inc.
300 Technology Square 3Rd Floor
Cambridge, Massachusetts 02139
USA
Tel: (617) 354-8100
Fax: (617) 354-8300